SCHEMBL25959208

SCHEMBL25959208

CCN1CCC1CN(C)C

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.36
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14509624 0.87 SIGMAR1 (0.47) SIGMAR1ALDH1A1HTTL3MBTL1
SCHEMBL12347386 0.87 SIGMAR1 (0.47) SIGMAR1ALDH1A1HTTL3MBTL1
SCHEMBL8434986 0.85 SIGMAR1 (0.43) SIGMAR1ALDH1A1HTTL3MBTL1
SCHEMBL26204708 0.75
SCHEMBL22307602 0.75
SCHEMBL3265296 0.75
SCHEMBL23102877 0.74 PDK1 (0.36) SIGMAR1
Hydrochloric Acid SCHEMBL28684997 0.73
Ammonia Solution, Strong SCHEMBL29237037 0.73
SCHEMBL18931313 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233569-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230233569-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS KRAS, HRAS, MTOR SIGMAR1 3617/4885ALDH1A1 4528/4885HTT 1473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.